Table: Torii Pharmaceutical - 9-MTH parent results
Oct 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2019 Sep 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 31.32 45.54 42.70
(-31.2 pct) (-0.4 pct) (-31.7 pct)
Operating 662 mln 3.04 700 mln
(-78.2 pct) (-16.8 pct) (-85.9 pct)
Recurring 839 mln 3.13 1.00
(-73.2 pct) (-16.1 pct) (-80.3 pct)
Net 26.47 2.25 25.70
(-18.9 pct)
EPS 942.93 yen 80.14 yen 915.62 yen
EPS Diluted 80.14 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)